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Abstract 1 
Over the past century, numerous studies have used oral biofilm models to investigate 2 
growth kinetics, biofilm formation, structure and composition, antimicrobial 3 
susceptibility and host-pathogen interactions. In vivo animal models provide useful 4 
models of some oral diseases; however, these are expensive and carry vast ethical 5 
implications. Oral biofilms grown or maintained in vitro offer a useful platform for 6 
certain studies and have the advantages of low cost of establishing such models, as 7 
well being easy to reproduce and manipulate. In addition, a wide range of variables 8 
can be monitored and adjusted to mimic the dynamic environmental changes at 9 
different sites in the oral cavity, such as pH, temperature, salivary and gingival 10 
crevicular fluid flow rates, or microbial composition. This review provides a detailed 11 
insight for early-career oral science researchers into how biofilm models used in oral 12 
research have progressed and improved over the years, their advantages and 13 
disadvantages, and how such systems have contributed to our current understanding 14 
of oral disease pathogenesis and aetiology.  15 
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Introduction 1 
Polymicrobial oral biofilms consist of many bacterial and fungal species. 2 
Approximately 700 bacterial species or phylotypes (1) and more than 100 fungal 3 
species (2) have been identified in the oral cavity. It is estimated that overall species 4 
numbers may well exceed 1000, although many of these are uncultivated (3). There 5 
is significant diversity in the oral microbiome, varying greatly from person to person. 6 
For example, only 100-200 microbial species are thought to be found in the oral cavity 7 
of any given individual (4). Despite this diversity, the concept of microbial “complexes” 8 
of microorganisms has emerged, which demonstrates a shift in biofilm colonisation 9 
from health to disease, such as in the development of periodontal diseases (5, 6). Our 10 
understanding of how dental plaque composition relates to oral health and disease 11 
have also changed over time. For example, hypotheses such as the “non-specific 12 
plaque hypothesis” (7) “specific plaque hypothesis” (8), “ecological plaque hypothesis” 13 
(9) and “keystone pathogen hypothesis” (10) were all developed over the past 50 14 
years. Throughout time, these hypotheses have set the foundations of future oral 15 
microbiological research, ultimately contributing to our current understanding of the 16 
complex nature behind microbial disease onset and progression in the oral cavity. 17 
Recently, OMICs approaches (e.g., genomics, transcriptomics, proteomics and 18 
metabolomics) have enhanced our understanding of microbial interactions in the oral 19 
cavity, and it is now possible to identify all microbial species that colonise our mouths 20 
(3, 11). The OMICs platforms provide the power to investigate complex systems in 21 
unprecedented detail, and these have been used to examine biofilms in human 22 
diseases and in animal models of disease. Nonetheless, in vitro biofilm models provide 23 
useful systems for oral microbiologists and immunologists. In the following sections 24 
we will discuss how oral biofilm models have advanced over the past century and 25 
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appraise their value in understanding the pathophysiology of oral disease throughout 1 
each era. 2 
 3 
 4 
The initial discoveries in oral microbiology – “the pioneers”  5 
Over three centuries ago, Antoni van Leeuwenhoek was the first to observe that 6 
bacteria resided in the oral cavity. His descriptions of the ‘white matter between teeth’ 7 
(now known as ‘dental plaque’) and hand-drawn pictures of plaque observed through 8 
a homemade light microscope were later found to likely represent Streptococcus 9 
chains, rod‐shaped Actinomyces and Fusobacteria, and spiralling forms of 10 
spirochetes. However, it would not be until the late 19th and early 20th century that 11 
scientific research would begin to truly increase our knowledge of the microorganisms 12 
that colonise the oral cavity. In 1952, Pigman et al (12) proposed that Magitot was the 13 
first to conceive the early ideas for in vitro oral microbiology work as far back as 1878, 14 
which involved the simple process of incubating extracted teeth in culture media. At a 15 
similar time, Black and Miller postulated that accumulation of bacteria in dental plaque 16 
facilitated pathogenicity (13, 14), which has now been superseded by modern-day 17 
hypotheses e.g., the ecological plaque and keystone pathogen hypothesis. This early 18 
work collectively resulted in the identification of cariogenic Streptococcus species, 19 
including Streptococcus mutans, which was named by Clarke in 1924 and later found 20 
to play an aetiological role in experimental caries in 1960 by Fitzgerald and Keyes 21 
(15). These studies led to an increase in the number of researchers investigating oral 22 
bacterial interactions in vitro.  23 
 24 
 25 
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A foundation for in vitro plaque research - “the early colonisers” 1 
Following further confirmation of the causal link between cariogenic streptococci and 2 
dental caries during the 1960s (16-18), oral microbiologists took a reductionist 3 
approach and turned to assessing the nutritional requirements, culture conditions and 4 
plaque forming-capabilities of S. mutans and other cariogenic bacteria (19-24). 5 
However, most of this work was limited to the use of bacterial culture in planktonic 6 
suspension, which we now know does not reflect the true conditions observed in the 7 
oral cavity. Such investigations on S. mutans led to the development of the “specific 8 
plaque hypothesis” by Loesche (8), who proposed that S. mutans along with other 9 
Streptococcus and Lactobacillus species were specific pathogens responsible for 10 
dental caries. As with most microbial-induced diseases, the search was then on for 11 
identifying a ‘gold-standard’ active compound that could target specific pathogens in 12 
the oral cavity. In 1970, Gjermo et al (25) was one of the first to assess the 13 
antimicrobial effects of multiple compounds on plaque samples formed in vivo and in 14 
vitro. One of the compounds tested, chlorhexidine gluconate (CHX), is now the main 15 
component of many commercial mouthwashes. Other studies subsequently showed 16 
that CHX was a broad-spectrum anti-septic against most oral microorganisms (26, 27). 17 
Unfortunately, due to limitations in microbiological techniques, much of the work at the 18 
time was restricted to utilising undefined plaque samples with unknown composition, 19 
meaning reproducibility was low, or largely unachievable. An improvement in culture-20 
based methods in the 1970s, including the development of anaerobic jars and 21 
cabinets, expanded the breadth of in vitro research. The ability to grow strict 22 
anaerobes led to the identification of pathogens associated with PD. Consequently, a 23 
range of anaerobic bacteria such as Bacteroides gingivalis (now known as 24 
Porphyromonas gingivalis) were isolated from PD lesions (28). Research throughout 25 
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this period concentrated on producing robust methods for isolating and cultivating 1 
anaerobic bacteria from plaque (29, 30). As a result, the “non-specific plaque 2 
hypothesis” and “specific plaque hypothesis” were adjusted to take into account 3 
specific anaerobic pathogens associated with PD (7, 31).  4 
 5 
An advancement in microscopic techniques also meant that in vitro oral research 6 
began to flourish throughout the 1970s. The first scanning electron microscope (SEM) 7 
and transmission electron microscope (TEM) were made commercially available 8 
during this time, meaning that the morphology and architecture of individual colonies 9 
and cell aggregates in plaque could be imaged. Publications by Sudo and colleagues 10 
(32, 33) described the development of a model to assess continuous culture of saliva 11 
samples on substrates of glass beads coated with hydroxyapatite (HA) to mimic the 12 
tooth surface. SEM images provided evidence of bacterial colonization on the HA-13 
coated beads with distinct cell-cell interactions between different bacterial species 14 
(33). Others followed suit with multiple studies reporting the use of SEM and TEM 15 
technology to image plaque formed both in vivo and in vitro (34-36). It was arguably 16 
the combination of culture-based methods and microscopy at the time that helped us 17 
to understand the complex polymicrobial interactions between different species in 18 
plaque. Accordingly, it was at a similar time that the phrase “biofilm” was initially coined 19 
by Costerton in 1978 (37), a term that is now synonymous with oral microbiology. 20 
 21 
 22 
 23 
 24 
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Bridging the gap with chemostat models – “the intermediate 1 
colonisers” 2 
Multiple research groups reacted to this new way of considering oral microbial plaque 3 
and started to utilise continuous cultures to generate “biofilms” under appropriate 4 
controlled conditions (e.g., under shear force and constant flow). This technique, which 5 
utilises a chemostat flow system, allows for the growth of planktonic cultures and 6 
biofilms through a regular supply of fresh medium, continuously pumped through the 7 
system, with spent growth medium being removed at a similar rate (Figure 1A). The 8 
idea of the chemostat was first described in 1950 as a method to culture a bacterial 9 
population at a reduced growth rate (38, 39). Continuous culture models were 10 
revolutionary for oral biofilm research although most early work using the technology 11 
was restricted to planktonic mono- or mixed-cultures. Throughout the 1970s, the 12 
metabolic and enzymatic activity of cariogenic microorganisms were assessed 13 
following growth in chemostat systems pumped with different carbohydrates such as 14 
sucrose, fructose and glucose (33, 40-42). However, it was undoubtedly the 15 
pioneering work of Marsh who instigated the use of the chemostat in oral microbiology, 16 
driving the field forward during the 1980s. His early chemostat work was limited and 17 
was used to measure the growth rate of 1-2 bacterial species or undefined plaque 18 
samples in nutrient-excess or limited media (43, 44). However, later in the decade, 19 
defined mixed-species containing a more complex consortium of anaerobic 20 
microorganisms such as Fusobacteria, Actinomyces, Veillonella, Neisseria and 21 
Bacteroides species were introduced into chemostat systems under standardised 22 
conditions. Whilst reductionist in nature, these studies were some of the first to piece 23 
together interactions between different species which relatively reflected in vivo 24 
plaque, and subsequently led to the formulation of the “ecological plaque hypothesis” 25 
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(9). Of note at the time, the works of McKee et al (45), McDermid et al (46) and 1 
Bradshaw et al (47) all demonstrated that mixed-species cultures were influenced by 2 
carbohydrate availability, and subsequent shifts in pH. In these studies, cultures were 3 
pulsed with carbohydrate-rich media resulting in the generation of an acidic 4 
environment (following carbohydrate fermentation by cariogenic microorganisms), 5 
before the pH was adjusted back to neutral. This technique ultimately replicates the 6 
environment of the oral cavity after a consumption of a carbohydrate-rich meal, but 7 
also accounts for the return to a relatively neutral pH between meals. Additionally, as 8 
the pH at certain oral sites may be slightly alkaline (48, 49), chemostats provided an 9 
excellent platform for growing mixed-species biofilms in a highly controlled manner, in 10 
environments that closely mimic different sites of the oral cavity.  11 
 12 
By the late 1980s and early 1990s, chemostat systems were utilised for biofilm growth, 13 
as well as assessing the impact of nutrient availability on plaque composition and in 14 
antimicrobial susceptibility biofilm testing (50-53). These flow-through models allowed 15 
for minimum inhibitory concentration (MIC) testing of anti-microbials such as triclosan, 16 
CHX, xylitol and fluoride against mixed-species biofilms. An advantage being that the 17 
compounds could be pulsed through the system using MIC or sub-MIC levels, or 18 
dosed appropriately to give a constant final concentration. This meant that the effects 19 
of such compounds could be assessed either directly on bacterial species, or 20 
indirectly, if inhibition of one species impacting on the growth of another, thus altering 21 
the homeostasis of the biofilm. In 1991, Marsh and colleagues (54) showed that S. 22 
mutans, Lactobacillus casei and Veillonella dispar (carbohydrate-fermenting, acid-23 
tolerant bacterial species) predominate a mixed-species biofilm in environments of 24 
carbohydrate excess, and subsequent acidic pH, whilst treatment with sodium fluoride 25 
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reduced the acid production, stabilising the biofilm and allowing other bacterial species 1 
to flourish. Similar mechanisms were proposed for pathogens associated with PD, with 2 
Bradshaw and colleagues demonstrating that anaerobic bacteria such as 3 
Fusobacterium nucleatum and P. gingivalis could only survive aerobic environments 4 
when grown in communities containing oxygen-consuming bacteria (55-57). It was 5 
around this time that Marsh proposed the “ecological plaque hypothesis”, which 6 
assumed that an imbalance in the composition of the oral biofilm due to environmental 7 
factors (carbohydrate accessibility and pH in dental caries), and nutrient availability 8 
(oxygen levels and redox potential in PD) can result in the enrichment of disease-9 
associated pathogens (9). Although chemostats do have evident disadvantages e.g., 10 
high risk of contamination and low throughput, the use of such systems provided an 11 
opportunity to mimic in vivo environments with higher accuracy than previously 12 
developed models.   13 
 14 
Throughout the 1990s, the concept of chemostat flow was utilised and adapted for 15 
other continuous culture systems. A constant depth film fermenter (CDFF) used the 16 
principle of chemostat flow to reproducibly grow a large mass of biofilm with defined 17 
thickness for imaging, antimicrobial testing and inter-species transfer of drug 18 
resistance genes (58-61). Flow cells, which are slides containing suitable substrata 19 
such as HA, were also introduced into chemostat systems to assess biofilm formation 20 
and allow for microscopic imaging of the biofilm development. In 1994, Herles and 21 
colleagues (62) utilised a chemostat-flow cell system to study the effects of different 22 
anti-plaque agents on biofilms formed on flow cells. Their work qualitatively showed 23 
that multi-species biofilms formed in vitro were susceptible to triclosan-containing 24 
mouth-rinse, whilst untreated biofilms remained largely viable. Interestingly, at a 25 
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similar time, Singleton et al (63) combined flow cell technology with fluorescence 1 
microscopy to map spatial distribution of bacterial species within plaque using 2 
mathematical modelling. Others have used flow-cell systems in conjunction with 3 
fluorescence microscopy for imaging interactions between organisms (64-66). Cook, 4 
Costerton & Lamont (64) were the first to show that Streptococcus gordonii forms an 5 
attachment substratum on saliva-coated flow-cell coverslips for P. gingivalis using 6 
confocal laser scanning electron microscopy (CLSM). Thus, fluorescence microscopy 7 
highlighted key microbial interactions like never before.  8 
 9 
Maturation of modern-day models – “the late colonisers”  10 
Microbiological models – from plaque to plate 11 
Static biofilm models became important systems in the field of oral microbiology during 12 
the 1990s. These models exploited a relatively simple method of producing biofilms to 13 
perform high-throughput antimicrobial susceptibility testing and phenotypic screening 14 
of mutant libraries to assess the importance of certain genes in biofilm formation (67-15 
69). Oral biofilms were grown on either plastic, glass, HA coated-substrates, directly 16 
in the bottom of different sized microtiter plates, or on inverted pegs placed into specific 17 
media with inoculum (Figure 1B). The latter method known as the Calgary Biofilm 18 
Device (CBD) or minimum biofilm eradication concentration (MBEC) assay was first 19 
described by Ceri et al in 1999 (70). The CBD method remains used to this day, 20 
particularly for antimicrobial testing on undefined plaque samples cultured in vitro on 21 
inverted pegs (71-73). One major advantage of these static models is that multi-22 
species biofilms can be grown in large quantities, an improvement of chemostat flow 23 
systems which were restricted to producing no more than a few biofilms at any given 24 
time. In the present day, modern high-throughput techniques for oral biofilm cultivation 25 
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have been developed, e.g., microfluidics for miniaturising biofilm culture and 1 
characterisation (74-76) and impedance-based technology for real time monitoring of 2 
biofilm growth (77) (Figure 1C). However, these new techniques are expensive and 3 
therefore batch methods for growing biofilms in microtiter plates are arguably the 4 
preferred choice for the majority of research groups given the cost attached to 5 
generating such models. Additionally, these high-throughput approaches serve as 6 
ideal models employed by industry, which seek robust, minimalistic biofilm platforms 7 
that can be used as definitive test-beds for standardised biofilm testing (78, 79). 8 
Advantages and disadvantages of the continuous flow models, static biofilm systems 9 
and current high-throughput modern-day options utilising new technology are 10 
discussed in greater depth in Table 1. 11 
 12 
From the turn of the millennium, many research groups began to utilise high-13 
throughput static systems to develop their own multi-species biofilms from a defined 14 
number of microorganisms (Table 2). The increase in commercially available real-time 15 
quantitative polymerase chain reaction (RT-qPCR) machines in the early 2000s made 16 
this possible, meaning oral biofilm models could be grown to precise composition. 17 
Previously, compositional analysis was largely restricted to using selective and 18 
differential media for identification of different microbial species grown in multi-species 19 
biofilms. Currently, the use of genus- or species-specific primers in conjunction with 20 
microscopic technology means that biofilms can be repeatedly grown with 21 
reproducible composition and architecture (Figure 2A) (80). In addition, it is now 22 
possible to discriminate between viable or dead microbial species in biofilms using 23 
RT-qPCR methods. In 2011, Loozen et al (81) described a protocol using a DNA 24 
intercalating substance called propidium monoazide to identify the proportion of dead 25 
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S. mutans, Prevotella intermedia and Aggregatibacter actinomycetemcomitans cells 1 
in heat-killed mono-cultures. Since development, this method has become an 2 
important tool in assessing the effectiveness of antimicrobials and other actives on 3 
oral biofilms (82, 83) 4 
 5 
Immunology based models – the host-biofilm interface 6 
In the last two decades, oral immunologists have started to utilise these defined multi-7 
species biofilms to identify mechanisms involved in oral disease pathogenesis and 8 
aetiology. As such, co-culture mammalian cell-biofilm models are now frequently used 9 
in oral health and disease research (Figure 2B). Co-culture models have been 10 
described using primary and immortalised cell lines (e.g., immune cells including T 11 
cells, B cells, neutrophils and monocytes, primary human oral or gingival epithelial 12 
cells and immortalised cell lines such as OKF4, OKF6/TERT2 or TR146) and multi-13 
layered tissues (e.g., in-house 3D tissue models containing keratinocytes and 14 
fibroblasts or commercially available organotypic tissue). Results from multiple 15 
research groups have shown that cell viability and immune response in orally relevant 16 
cell lines or tissues can vary depending on biofilm complexity, composition and viability 17 
(84-86). These studies have demonstrated that commensal and pathogenic microbial 18 
species differentially modulate the epithelial immune response. For example, oral 19 
epithelial cells challenged with biofilms containing only commensal, health-associated 20 
microorganisms result in a minimal pro-inflammatory response, whilst biofilms 21 
comprised of disease-associated pathogens can induce an elevated pro-inflammatory 22 
gene- and protein- signature and induce cytotoxicity. It was in vitro co-culture research 23 
that showed planktonic P. gingivalis can invade oral epithelial cells and impair cytokine 24 
production (87-89). For example, interleukin-8 (IL-8) production is diminished by a 25 
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serine phosphatase and degraded by the cysteine proteases called gingipains 1 
produced by P. gingivalis (90, 91). Others have shown that oral epithelial cells co-2 
cultured with P. gingivalis-containing biofilms result in reduced IL-8 protein detection 3 
in spent cell supernatants (85, 92). Cytokine degradation may explain the “local 4 
chemokine paralysis” by which P. gingivalis delays the recruitment of neutrophils to 5 
the gingival tissue, impairing the mucosal defence to the pathogen in vivo, and 6 
ultimately evading the immune system (87). The plethora of oral biofilm and cell co-7 
culture models now available means that it is possible to investigate the mechanistic 8 
pathways that oral pathogens (and commensals) utilise to facilitate inflammation in a 9 
highly controlled manner in vitro. Despite their simplicity, these in vitro studies provide 10 
a strong foundation for on-going in vivo research.  11 
 12 
Imaging biofilms – Spying on the community 13 
Microscopy techniques have advanced in recent years; light, fluorescent and electron 14 
microscopic technology are now common methodologies for imaging oral biofilms in 15 
most laboratories (Figure 2C). In addition, these methods, in particularly fluorescent 16 
microscopy, have been adapted for more unique investigations in oral biofilm 17 
research. For example, an interesting technique described by Schlafer et al (93) 18 
utilising a ratiometric pH-sensitive dye called C-SNARF-4 has been applied to oral 19 
biofilms to monitor changes in pH in the biofilm landscape. A five-species early dental 20 
plaque biofilm containing four Streptococcus species and A. naeslundii was grown in 21 
the presence and absence of artificial saliva containing 0.4% glucose, and pH 22 
gradients in the extracellular matrix monitored fluorescently. Regions within the biofilm 23 
with higher cell density correlated with lower pH values (93).  24 
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Fluorescent in situ hybridization (FISH), a technique allowing for sensitive identification 1 
of target microorganisms within complex microbial communities, has been used in 2 
imaging of oral biofilms, sampled directly from volunteers, or grown in vitro. Thurnheer, 3 
Gmur and Guggenheim (2004) were the first to combine FISH and CLSM to stain six 4 
species of bacteria and fungi within in vitro-grown oral biofilms (94). All six microbial 5 
species were identified using fluorescently labelled 16S or 18S rRNA-targeted 6 
oligonucleotides, with biofilms containing S. oralis, Streptococcus sobrinus, Veillonella 7 
dispar, F. nucleatum, Actinomyces naeslundii and Candida albicans visualised from 8 
two experiments (e.g., two independent triple-hybridisations using three different 9 
fluorescent probes). Other publications have used similar methods to show localisation 10 
of different bacterial species in mixed-species biofilms using multiple independent 11 
hybridisations (80, 95). A publication by Kommerein et al (2017) effectively showed 12 
the development of a robust four-species biofilm model with highly reproducible 13 
biomass and architecture as assessed by FISH (80). It is now possible to use 14 
additional combinations of fluorophores to identify tens of bacterial species in dental 15 
plaque. A publication by Valm (96) elegantly described an “proof of concept” imaging 16 
technique which combines fluorescent labelling coupled with spectral image 17 
acquisition and analysis to identify 15 different oral taxa in dispersed dental plaque. 18 
The technology, which is known as Combinatorial Labelling and Spectral Imaging 19 
(CLASI-FISH), has scope to distinguish between 120 different fluorescently-labelled 20 
microorganisms in a single image (97). In 2016, Mark-Welch et al (98) used CLASI-21 
FISH to visualise the “biogeography of the human oral microbiome” in intact dental 22 
plaque. The study utilised a nine- and ten-probe set of fluorescently labelled probes to 23 
demonstrate that oral biofilms formed unique ‘hedgehog-like’ structures predominated 24 
by Corynebacterium filaments that provide a “scaffold” for other microorganisms such 25 
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as Streptococcus and Porphyromonas species. To date, no studies have investigated 1 
the feasibility of identifying over 100 microorganisms in dental plaque using CLASI-2 
FISH, nor have any studies applied the technology to oral biofilms grown in vitro. 3 
However, it would be of great importance to assess whether microbial interactions in 4 
laboratory-grown polymicrobial biofilms recapitulate such complex spatial 5 
organisations in plaque formed in vivo.   6 
 7 
Spreading into other technologies – “biofilm dissemination” 8 
Throughout the last 20 years, the use of high throughput technologies has become 9 
routine to support biological discoveries and drive hypotheses. OMICs approaches 10 
have enabled researchers to view the genomics, transcripts, metabolites and proteins 11 
of oral biofilm models in a “holistic” manner. 12 
 13 
Microbiome analysis by shotgun sequencing or 16S amplicon sequencing has become 14 
one of the most widely used technologies and bioinformatic techniques in the 15 
microbiologist’s toolbox. Within the last 10 years there has been an increase in 16 
microbiome studies due to the cost of the sequencing technologies decreasing and 17 
the availability of analysis pipelines and packages increasing (99-101). The 18 
microbiome has been studied in caries, PD, denture stomatitis, peri-implantitis among 19 
several other oral diseases (102-105). These studies have allowed for the greater in-20 
depth characterisation of distinct microbial community shifts within the oral cavity, also 21 
accounting for uncultivated organisms. Large-scale molecular techniques such as 22 
microbiome sequencing have allowed for the identification of species, as well as 23 
species-species interactions and environment-species interactions previously 24 
undeterminable with conventional techniques. In periodontitis, such techniques have 25 
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uncovered unique characteristics exhibited by the sub-gingival plaque biofilm in health 1 
and disease. For example, Abusleme et al., (106) highlighted that in contrast to 2 
infections occurring in other sites of the body where diversity has been shown to 3 
decrease during active disease, in periodontitis, the diversity of sub-gingival plaque 4 
significantly increases in relation to health. Similarly, analysis of the sub gingival 5 
plaque microbiome has revealed that disease associated organisms may extend far 6 
beyond the previously identified ‘Red-complex’. Of note, organisms such as Filifactor 7 
alocis and Prevotella denticola have been consistently found to be higher in diseased 8 
sites (107-109). Together, such analysis has led to the re-evaluation of individual 9 
pathogens driving a disease state, and it is now hypothesised that “ecotypes” and/or 10 
whole microbial communities may drive dysbiosis and pathogenesis (110, 111).  11 
 12 
The sequencing of messenger RNA for studying transcriptomics is a powerful tool to 13 
gain insight into how an organism is reacting to and adapted to its environment. This 14 
can give us clues and hypotheses about how microorganisms interact in a complex 15 
biofilm environment. For example, the use of RNA-Seq has helped in our 16 
understanding of species-species adhesion and virulence mechanisms between C. 17 
albicans and P. gingivalis (112), and synergistic relationships in C. albicans and S. 18 
mutans biofilms (113). Transcriptomic studies have also been indispensable in 19 
understanding disease pathogenesis, drug resistance mechanisms and community 20 
dynamics with regard to oral biofilm research in recent years (114, 115). In a study by 21 
Frias-Lopez et al (114), it was shown that incorporation of periodontal pathogens (e.g., 22 
P. gingivalis) into biofilms containing commensal species can alter patterns in gene 23 
expression in the healthy oral community.  24 
 25 
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Similarly, Mass Spectrometry (MS) and Nuclear Magnetic Resonance (NMR) have 1 
allowed for snapshot profiling of metabolic and protein expression for the identification 2 
of signatures in oral biofilms. Metabolomics enables the identification and relative 3 
quantification of all the metabolites in a biological system. Metabolomic pathways and 4 
biofilm regulatory mechanisms are discernible with these technologies (116). They 5 
offer the potential to identify signatures associated with disease progression. This was 6 
highlighted in a 2015 pilot study which validated the use of metabolomics by Gas 7 
Chromatography–MS in identifying metabolic profiles between cariogenic and 8 
disease-free oral biofilms (117). Advancements have also been made in oral microbial 9 
studies which allow for the correlation of the metabolome with shifts in the oral 10 
microbiome (110). These studies further our understanding of bacterial communities 11 
with different ecological states with more specialised function, which the authors of the 12 
2017 study (110) suggest could highlight specific metabolic function of communities 13 
which could indicate dysbiosis. In the coming years, it is likely that the use of OMICs 14 
approaches in investigating microbial-host interactions will continue to grow. It is 15 
important that these techniques should be utilised in conjunction with laboratory 16 
science, in order to identify mechanistic pathways by which oral pathogens facilitate 17 
disease onset and progression.  18 
  19 
Conclusion 20 
We have highlighted in this review how our understanding of oral microbiology at any 21 
given time has resulted in relevant robust biofilm models, often simple to start with, but 22 
developing complexity over time. On the contrary, in vitro biofilm models have also 23 
enhanced our knowledge of the simple and complex microbial interactions in the oral 24 
cavity. Recent OMICs analyses imply that no oral biofilm model is ideal, and that it is 25 
18 
 
simply impossible to replicate exact microbial-microbial or microbial-host interactions 1 
in vitro. Nonetheless, understanding how a few organisms interact together in biofilms, 2 
and with host immunity, aids our view of microbial and host dynamic interactions. We 3 
should not lose sight of the importance of hypothesis-driven research when creating 4 
or using these models, and not simply rely on ‘big data’ to shape our ideas and become 5 
more speculative in our outlook. As with all approaches, OMICs techniques are not 6 
devoid of disadvantages. Whilst offering powerful platforms to investigate a large 7 
number of variables simultaneously, issues persist over poor reproducibility and 8 
statistical bias. As such, there remains a requirement for such approaches to be 9 
supplemented with accessible and reproducible in vitro assays. In the future, 10 
combining results from OMICs studies, in vivo animal models, and in vitro biofilm 11 
research will undoubtedly continue to enhance our knowledge of oral disease 12 
aetiology and pathogenesis, consequently impacting clinical practice and disease 13 
treatment.  14 
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Figures and Tables  1 
Figure 1 – Models used to grow oral biofilms. Early work focused on the use of 2 
continuous flow systems such as the chemostat model which offered the advantage 3 
of a regular supply of fresh medium whilst maintaining a constant media volume (A). 4 
However, such models were hindered by low-throughput, leading to the development 5 
of high-throughput static biofilm models (B). Since development, static biofilms have 6 
become the most ubiquitously used models in oral research and encompass the 7 
conventional model; where biofilms are grown in microtiter plates, and the Calgary 8 
device; where biofilms are grown on pegs attached to the surface of lids. As the field 9 
of biofilm research continues to grow, novel systems have been employed to 10 
incorporate the advantages of continuous flow and static models. One such model is 11 
the microfluidic device, which uses microchannels to combine continuous media flow 12 
with high-throughput screening potential (C). Image created by Biorender. 13 
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 18 
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 20 
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 22 
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 24 
26 
 
Figure 2 - Different methodologies used to investigate oral biofilms. There are 1 
three main outputs used to generate data from biofilm models described in this review; 2 
microbiological, immunological and microscopic methods. Modern investigations seek 3 
to analyse the composition of in vitro-grown polymicrobial biofilms using quantitative 4 
PCR and species- or genus- specific primer sets, whilst omics approaches have been 5 
used to investigate the unique transcriptome profiles of microorganisms associated 6 
with health and disease (A). Co-culture systems are now commonplace in oral biofilm 7 
research. These involve the simultaneous incubation of biofilms with immune cell 8 
types such as gingival epithelial cells to assess host-pathogen interactions and better 9 
understand the underlying pathologies of oral disease (B). Microscopic techniques 10 
include the use of simple light microscopy to observe general organism topography 11 
within biofilms, fluorescent microscopy (e.g. FISH) to highlight organism viability and 12 
scanning electron microscopy (SEM) to visualise distinct cell-cell aggregates 13 
encapsulated within a biofilm (C). Image created by Biorender. 14 
 15 
 16 
 17 
 18 
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Model Description Advantages Disadvantages 
Continuous flow models     
Chemostat 
A bioreactor system with a 
continuous inflow of fresh 
media and sterile air, waste 
media is removed at the same 
rate to maintain a constant 
culture volume. Biofilms form 
within the culture chamber. 
Suitable for growth of large biofilms.  
Continuous flow of fresh media. 
Allows for control of the external 
environment which can influence 
biofilm growth.  
Low through-put. 
Requires specialised 
equipment.  
Large quantity of material 
lost if contaminated.  
No direct access to biofilms. 
Prone to contamination. 
Flow-cell 
Slides containing suitable 
substrata which allow biofilms 
to form within small channels 
under a constant flow of media. 
Spent media is removed   
Allows for direct visualisation of 
biofilm growth stages.  
Optimised for microscopy.  
Compatible with a range of 
substrata.  
Continuous flow of fresh media.   
Low through-put. 
Requires specialised 
equipment.  
No direct access to biofilms.  
Prone to contamination. 
Constant depth 
film fermenter 
Coupons are suspended from 
the lid via a suitable coupon 
holder. Fresh media is pumped 
through the reactor, with 
continuous mixing. Biofilms 
form on the surface of coupons. 
Commercially available.  
Continuous flow of fresh media.  
Allows for direct access to biofilms.  
Can alter shear stress.  
Low through-put 
Requires specialised 
equipment.  
Expensive.   
Prone to contamination. 
Static models 
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Microtiter plate 
Media containing bacteria is 
placed into microtiter plate. 
Biofilms form on the bottom of 
wells, or on suitable substrates 
placed in each well. Media can 
be replaced through pipetting.   
High through-put. 
Inexpensive.  
No specialised equipment required.  
Microtiter plates with varying well 
sizes can be used to better suit the 
desired assay.  
Biofilms not grown under 
continuous flow. 
Prone to sedimentation. 
Multiple plates required for 
continuous timepoint 
assays.  
Labour intensive.  
Calgary device 
Media containing bacteria is 
placed into 96-well microtiter 
plates. Pegs suspended from 
lids are placed into wells, 
allowing for biofilm formation on 
their surface.  
High through-put 
Allows for easy manipulation of 
culture media.  
Requires active attachment of 
bacteria as opposed to 
sedimentation. 
More expensive than simple 
microtiter plates.   
Multiple plates required for 
continuous timepoint 
assays.  
Prone to contamination.  
Labour intensive.  
Modern technologies  
Microfluidics 
(e.g., BioFlux 
microfluidic 
devices) 
Small microfluidic chips contain 
channels etched into a suitable 
substrate (glass, silicon, plastic) 
which are connected through 
inlets and outlets. Media is 
pumped through channels, 
allowing for micro-biofilm 
formation.  
High through-put. 
Can be designed to mimic specific 
environments.  
Suitable for antimicrobial 
susceptibility testing. 
Allows for analysis of different 
stages of biofilm growth.  
Expensive.  
Requires specialised 
equipment for preparation 
and analysis.  
Clogging may occur in 
micro-channels.   
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Impedance-
based 
technology 
(e.g., 
XCELLigence 
real-time 
monitoring 
system) 
Media containing bacteria is 
placed into microtitre E-plates 
with gold electrodes on the 
plate floor. Electron impedence 
is used to monitor several 
factors such as biofilm growth 
and cell morphology. Cell index 
values directly related to biofilm 
maturation. 
High through-put. 
Allows for real-time monitoring of 
biofilm growth. 
Suitable for antimicrobial 
susceptibility testing. 
Can allow for direct access to the 
biofilm. 
Expensive. 
Requires specialised 
equipment for preparation 
and analysis.  
Prone to sedimentation. 
Gold electrodes can be 
fragile and easily damaged. 
 1 
Table 1 – Advantages and disadvantages of current oral biofilm methodologies. A table showing the current methodologies 2 
used by research groups for growth of oral biofilm models including continuous flow systems, static models and current modern 3 
options utilising new technology. A description of the models, advantages and disadvantages are highlighted for each methodology.   4 
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Authors Biofilm Bacterial/fungal strains Substratum Media Reference 
Guggenheim et al., 
2001 * 
Supra-gingival 
biofilm 
Streptococcus oralis, Streptococcus 
sobrinus, Veillonella dispar, 
Actinomyces naeslundii & 
Fusobacterium nucleatum  
Saliva-coated 
hydroxyapatite 
disc 
Human saliva, 
human serum 
and modified 
universal fluid 
medium 
(118) 
Guggenheim et al., 
2009 * and 
Ammann et al., 
2012 
Sub/Supra-
gingival biofilm 
Streptococcus intermedius, 
Streptococcus oralis, 
Campylobacter rectus, 
Fusobacterium nucleatum spp. 
vincentii, Veillonella dispar, 
Actinomyces naeslundii, 
Porphyromonas gingivalis, 
Prevotella intermedia, Tannerella 
forsythia & Treponema 
lecithinolyticum or Treponema 
denticola 
Saliva-coated 
hydroxyapatite 
disc 
Human saliva, 
human serum 
and modified 
universal fluid 
medium 
(95, 119) 
Peyyala et al 2013 
* 
Health, gingivitis, 
periodontitis 
biofilms 
Streptococcus gordonii, 
Streptococcus oralis & 
Streptococcus sanguinis (health), 
Streptococcus gordonii, 
Actinomyces naeslundii & 
Fusobacterium nucleatum 
(gingivitis), Streptococcus gordonii, 
Fusobacterium nucleatum & 
Porphyromonas gingivalis 
(periodontitis) 
Rigid gas 
permeable 
hard contact 
lenses 
Supplemented 
brain heart 
infusion broth  
(84) 
Frias-Lopex and 
Pinedo, 2012 
Health, 
periodontitis 
biofilms 
Actinomyces naeslundii, 
Lactobacillus casei, Streptococcus 
mitis, Veillonella parvula & 
Fusobacterium nucleatum (health) 
Saliva-coated 
hydroxyapatite 
disc 
Mucin growth 
medium 
(114) 
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including Porphyromonas gingivalis 
& Aggregatibacter 
actinomycetemcomitans 
(periodontitis) 
Falsetta et al 2014  Caries biofilm Streptococcus mutans & Candida 
albicans 
Saliva-coated 
hydroxyapatite 
disc 
Human Saliva (120) 
Millhouse et al 
2014 
Periodontitis 
biofilm 
Streptococcus mitis, Fusobacterium 
nucleatum, Porphyromonas 
gingivalis & Aggregatibacter 
actinomycetemcomitans 
ThermanoxTM 
coverslips 
Artificial Saliva (121) 
Muhammad et al 
2014 
Endodontic 
biofilm 
Enterococcus faecalis, 
Streptococcus salivarius, 
Porphyromonas gingivalis & 
Prevotella intermedia 
Extracted tooth Schaedler 
anaerobic 
broth 
(122) 
Cavalcanti et al 
2016 
Peri-implantitis 
biofilm 
Candida albicans, Streptococcus 
mutans, Streptococcus oralis, 
Veillonella dispar, Actinomyces 
naeslundii & Fusobacterium 
nucleatum 
Titanium 
coated discs 
Modified 
universal fluid 
medium with 
glucose 
(123) 
Sherry et al 2016 Denture 
stomatitis biofilm 
Candida albicans, Streptococcus 
intermedius, Streptococcus mitis, 
Streptococcus oralis, 
Aggregatibacter 
actinomycetemcomitans, 
Actinomyces naeslundii, Veillonella 
dispar, Fusobacterium nucleatum, 
Fusobacterium nucleatum spp. 
vincentii, Porphyromonas gingivalis 
& Prevotella intermedia 
Polymethylmet
hacrylate discs 
Artificial Saliva (83) 
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Thurnheer & 
Belibasakis, 2016 
Peri-implantitis 
biofilm 
Streptococcus oralis, Streptococcus 
anginosus, Actinomyces oris, 
Fusobacterium nucleatum, 
Veillonella dispar, Campylobacter 
rectus, Prevotella intermedia, 
Porphyromonas gingivalis, 
Tannerella forsythia, Treponema 
denticola, Staphylococcus aureus & 
Staphylococcus epidermidis 
Saliva-coated 
hydroxyapatite 
or titanium 
discs 
Human saliva, 
human serum 
and modified 
universal fluid 
medium 
(124) 
Kommerein et al., 
2017  
Peri-implantitis 
biofilm 
Streptococcus oralis,  
Actinomyces naeslundii,  
Veillonella dispar  
Porphyromonas gingivalis 
96-well glass 
bottom plate 
Supplemented 
brain heart 
infusion broth 
(80) 
Zhou et al., 2018 Caries biofilm Streptococcus mutans, 
Lactobacillus casei, Veillonella 
dispar, Actinomyces naeslundii & 
Fusobacterium nucleatum 
ThermanoxTM 
coverslips  
Artificial Saliva (125) 
Ramage et al., 
2019 * 
Denture 
Stomatitis 
Streptococcus mitis, Streptococcus 
intermedius, Streptococcus oralis, 
Candida albicans, Actinomyces 
naeslundii, Veillonella dispar, Rothia 
dentocariosa, Lactobacillus casei & 
Lactobacillus zeae  
Polymethylmet
hacrylate discs 
Artificial Saliva (126) 
 1 
Table 2 – The multi-species oral biofilm static models developed over the last 20 years. A table showing the range of oral 2 
biofilm static models developed by multiple research groups. Each model contains bacterial and fungal species associated with 3 
different health and disease states in the oral cavity. Asterisks denote models of major importance (*). In 2001, Guggenheim et al 4 
(118) was one of the first to describe the validation of a supra-gingival static biofilm model. Prior models to this work predominantly 5 
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utilised continuous culture systems such as chemostats or flow cells. The “Zurich” biofilm model was adapted by the same group 1 
(95) and made more complex including a total of 9- species associated with health and periodontitis. Using a combination of 2 
microbiological and microscopic techniques, the authors were able to comprehensively characterise the composition and 3 
architectural features of the biofilm, in addition to assessing the inflammatory outputs in a co-culture system with gingival cells. A 4 
number of studies have used the “Zurich” biofilm as a template for their own models. The Ebersole group (84) developed biofilm 5 
models for co-culture experiments, to study the host-pathogen response to biofilms containing a consortium of microorganisms 6 
associated with oral health and disease. The ensuing studies from the group have enhanced our understanding of the host 7 
response to commensal and pathogenic biofilms. A recent publication by Ramage et al (126) developed a complex denture plaque 8 
model using the dominant microbial genera from a microbiome study (104). Future models may serve to utilise OMICs approaches 9 
such as microbiome analyses to develop new biofilm models incorporating microorganisms newly associated with oral diseases 10 
such as denture stomatitis, periodontitis or endodontic infections.  11 
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